Literature DB >> 25766903

Dioxin inhibition of swim bladder development in zebrafish: is it secondary to heart failure?

Monica S Yue1, Richard E Peterson2, Warren Heideman2.   

Abstract

The swim bladder is a gas-filled organ that is used for regulating buoyancy and is essential for survival in most teleost species. In zebrafish, swim bladder development begins during embryogenesis and inflation occurs within 5 days post fertilization (dpf). Embryos exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) before 96 h post fertilization (hpf) developed swim bladders normally until the growth/elongation phase, at which point growth was arrested. It is known that TCDD exposure causes heart malformations that lead to heart failure in zebrafish larvae, and that blood circulation is a key factor in normal development of the swim bladder. The adverse effects of TCDD exposure on the heart occur during the same period of time that swim bladder development and growth occurs. Based on this coincident timing, and the dependence of swim bladder development on proper circulatory development, we hypothesized that the adverse effects of TCDD on swim bladder development were secondary to heart failure. We compared swim bladder development in TCDD-exposed embryos to: (1) silent heart morphants, which lack cardiac contractility, and (2) transiently transgenic cmlc2:caAHR-2AtRFP embryos, which mimic TCDD-induced heart failure via heart-specific, constitutive activation of AHR signaling. Both of these treatment groups, which were not exposed to TCDD, developed hypoplastic swim bladders of comparable size and morphology to those found in TCDD-exposed embryos. Furthermore, in all treatment groups swim bladder development was arrested during the growth/elongation phase. Together, these findings support a potential role for heart failure in the inhibition of swim bladder development caused by TCDD.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aryl hydrocarbon receptor; Development; Heart failure; Swim bladder; TCDD; Zebrafish

Mesh:

Substances:

Year:  2015        PMID: 25766903      PMCID: PMC4397172          DOI: 10.1016/j.aquatox.2015.02.016

Source DB:  PubMed          Journal:  Aquat Toxicol        ISSN: 0166-445X            Impact factor:   4.964


  31 in total

1.  2,3,7,8-Tetrachlorodibenzo-p-dioxin toxicity in the zebrafish embryo: altered regional blood flow and impaired lower jaw development.

Authors:  Hiroki Teraoka; Wu Dong; Shuji Ogawa; Shusaku Tsukiyama; Yuji Okuhara; Masayoshi Niiyama; Naoto Ueno; Richard E Peterson; Takeo Hiraga
Journal:  Toxicol Sci       Date:  2002-02       Impact factor: 4.849

Review 2.  The energetics of vertical migration by fishes.

Authors:  R M Alexander
Journal:  Symp Soc Exp Biol       Date:  1972

3.  Toxicity, histopathological alterations and immunohistochemical CYP1A induction in the early life stages of the seabream, Sparus aurata, following waterborne exposure to B(a)P and TCDD.

Authors:  J B Ortiz-Delgado; C Sarasquete
Journal:  J Mol Histol       Date:  2004-01       Impact factor: 2.611

4.  2,3,7,8-Tetrachlorodibenzo-p-dioxin activation of the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator pathway causes developmental toxicity through a CYP1A-independent mechanism in zebrafish.

Authors:  Sara A Carney; Richard E Peterson; Warren Heideman
Journal:  Mol Pharmacol       Date:  2004-09       Impact factor: 4.436

5.  Persistent adverse effects on health and reproduction caused by exposure of zebrafish to 2,3,7,8-tetrachlorodibenzo-p-dioxin during early development and gonad differentiation.

Authors:  Tisha C King Heiden; Jan Spitsbergen; Warren Heideman; Richard E Peterson
Journal:  Toxicol Sci       Date:  2009-03-11       Impact factor: 4.849

6.  Aryl hydrocarbon receptor 2 mediates 2,3,7,8-tetrachlorodibenzo-p-dioxin developmental toxicity in zebrafish.

Authors:  Amy L Prasch; Hiroki Teraoka; Sara A Carney; Wu Dong; Takeo Hiraga; John J Stegeman; Warren Heideman; Richard E Peterson
Journal:  Toxicol Sci       Date:  2003-07-25       Impact factor: 4.849

Review 7.  The search for endogenous activators of the aryl hydrocarbon receptor.

Authors:  Linh P Nguyen; Christopher A Bradfield
Journal:  Chem Res Toxicol       Date:  2007-12-13       Impact factor: 3.739

8.  Development of zebrafish swimbladder: The requirement of Hedgehog signaling in specification and organization of the three tissue layers.

Authors:  Cecilia Lanny Winata; Svetlana Korzh; Igor Kondrychyn; Weiling Zheng; Vladimir Korzh; Zhiyuan Gong
Journal:  Dev Biol       Date:  2009-05-05       Impact factor: 3.582

9.  The role of vasculature and blood circulation in zebrafish swimbladder development.

Authors:  Cecilia Lanny Winata; Svetlana Korzh; Igor Kondrychyn; Vladimir Korzh; Zhiyuan Gong
Journal:  BMC Dev Biol       Date:  2010-01-14       Impact factor: 1.978

10.  2,3,7,8-Tetrachlorodibenzo-p-dioxin exposure prevents cardiac valve formation in developing zebrafish.

Authors:  Vatsal Mehta; Richard E Peterson; Warren Heideman
Journal:  Toxicol Sci       Date:  2008-05-13       Impact factor: 4.849

View more
  4 in total

1.  Mechanistic Evaluation of Benzo[a]pyrene's Developmental Toxicities Mediated by Reduced Cyp19a1b Activity.

Authors:  Khalid M Alharthy; Faisal F Albaqami; Cammi Thornton; Jone Corrales; Kristine L Willett
Journal:  Toxicol Sci       Date:  2016-09-14       Impact factor: 4.849

2.  Grouping of chemicals into mode of action classes by automated effect pattern analysis using the zebrafish embryo toxicity test.

Authors:  E Teixidó; T R Kieβling; N Klüver; S Scholz
Journal:  Arch Toxicol       Date:  2022-03-07       Impact factor: 6.168

3.  Automated Morphological Feature Assessment for Zebrafish Embryo Developmental Toxicity Screens.

Authors:  Elisabet Teixidó; Tobias R Kießling; Eckart Krupp; Celia Quevedo; Arantza Muriana; Stefan Scholz
Journal:  Toxicol Sci       Date:  2019-02-01       Impact factor: 4.849

4.  Cardiovascular and Respiratory Toxicity of Protamine Sulfate in Zebrafish and Rodent Models.

Authors:  Joanna Miklosz; Bartlomiej Kalaska; Piotr Podlasz; Małgorzata Chmielewska-Krzesińska; Miłosz Zajączkowski; Adam Kosiński; Dariusz Pawlak; Andrzej Mogielnicki
Journal:  Pharmaceutics       Date:  2021-03-09       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.